Francesco Ferrara | Pharmacist | Innovative Research Award

Published on by Research Awards

Innovative Research Award

Francesco Ferrara – ASL Napoli 3 SUD, Italy
Francesco Ferrara
AffiliationASL Napoli 3 SUD
CountryItaly
Scopus ID59464334600
Documents1546
Citations2176
h-index27
Subject AreaPharmacist
EventInternational Research Awards
ORCID0000-0001-9298-6783

Francesco Ferrara is an Italian hospital pharmacist and researcher affiliated with ASL Napoli 3 SUD. His academic profile demonstrates extensive contributions to pharmacology, clinical pharmacy, healthcare governance, and therapeutic innovation. Through a substantial publication record and active international collaboration, he has contributed to evidence-based healthcare practices and multidisciplinary medical research.[1]

Abstract

This article evaluates the scholarly profile of Francesco Ferrara in relation to the Innovative Research Award. His research activities encompass pharmacology, healthcare management, antimicrobial resistance, chronic disease treatment, and pharmaceutical policy. The combination of publication productivity, citation influence, and interdisciplinary engagement highlights a sustained commitment to advancing healthcare knowledge and clinical practice.[1]

Keywords

Pharmacology, Clinical Pharmacy, Healthcare Governance, Drug Policy, Therapeutic Innovation, Antimicrobial Resistance, Pharmaceutical Research.

Introduction

Modern healthcare requires researchers capable of integrating clinical evidence, pharmaceutical management, and public health priorities. Francesco Ferrara has developed a multidisciplinary portfolio addressing therapeutic effectiveness, healthcare sustainability, and emerging treatment strategies. His work reflects contemporary priorities in patient-centered care and pharmaceutical innovation.[2]

Research Profile

Ferrara serves within the Italian Health Service and has accumulated professional experience across multiple healthcare institutions. His expertise includes clinical pharmacy, pharmacoeconomics, healthcare technology assessment, and pharmaceutical governance. The researcher maintains active participation in scientific publishing and peer-review activities across internationally recognized journals.[1]

Research Contributions

Key contributions include investigations into antimicrobial resistance, biosimilar medicines, chronic disease management, neurological disorders, dermatological therapies, and healthcare expenditure analysis. His research frequently combines clinical relevance with policy implications, supporting informed decision-making in healthcare systems and pharmaceutical practice.[3]

Publications

Publications

Francesco Ferrara has authored and co-authored an extensive portfolio of scholarly publications spanning pharmacology, clinical pharmacy, antimicrobial resistance, chronic disease management, dermatology, neurology, cardiovascular medicine, and healthcare governance. His research has appeared in internationally recognized journals including Inflammopharmacology, European Journal of Clinical Pharmacology, Pharmaceuticals, Antibodies, and Hospital Pharmacy. Through collaborations with multidisciplinary research teams, he has contributed to studies addressing therapeutic innovation, drug utilization, public health challenges, and evidence-based healthcare policies. The breadth and consistency of his publication record demonstrate sustained scientific productivity and a commitment to advancing pharmaceutical and clinical research across diverse healthcare settings.[2][3]

Research Impact

With more than two thousand citations and a substantial h-index, Ferrara’s scholarly output demonstrates measurable academic influence. His studies contribute to clinical practice, healthcare policy development, and pharmaceutical governance. The broad thematic coverage of his work illustrates a capacity to address both specialized and system-level healthcare challenges.[1]

Award Suitability

The Innovative Research Award recognizes individuals who demonstrate originality, sustained scholarly productivity, and meaningful research outcomes. Ferrara’s record of publications, international collaborations, and healthcare-focused investigations aligns with these criteria. His contributions support innovation in pharmacological science and evidence-based healthcare management.[4]

Conclusion

Francesco Ferrara has established a notable academic profile through sustained research activity, clinical expertise, and interdisciplinary collaboration. His contributions to pharmacology and healthcare policy provide practical and scholarly value. These achievements support his recognition as a strong candidate for the Innovative Research Award.[5]

References

    1. ORCID. (2026). Francesco Ferrara (ORCID iD: 0000-0001-9298-6783). ORCID Registry.
      https://orcid.org/0000-0001-9298-6783
    2. Ferrara, F., De Berardinis, F., Scognamiglio, M., & Zovi, A. (2026). The shifting paradigm of monoclonal antibodies in COVID-19 management: From early triumphs to viral resistance and future perspectives. Antibodies, 15(3), Article 48.
      https://doi.org/10.3390/antib15030048
    3. Ferrara, F. (2026). Therapeutic update on alopecia areata: A critical review of standard and emerging targeted therapies. Inflammopharmacology.
      https://doi.org/10.1007/s10787-026-02273-8
    4. Ferrara, F., Martellone, L., Vaccaro, M., Coluccia, A., Scognamiglio, M., Langella, R., Zovi, A., & Polito, G. (2025). Real-life impact of cefiderocol in carbapenem-resistant Acinetobacter baumannii infections (CRAb): A narrative review. European Journal of Clinical Pharmacology.
      https://doi.org/10.1007/s00228-025-03866-y
    5. Elsevier. (2026). Scopus Author Profile: Francesco Ferrara (Author ID: 59464334600). Scopus Preview.
      https://www.scopus.com/authid/detail.uri?authorId=59464334600

Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award | 13652

Published on by Research Awards

Dr. Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award |

Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Mekkanti Manasa Rekha, Pharm.D, RPh, (Ph.D.), APGDCR, AIPSD, FSASS, FSAB, LM-APTI, is an accomplished pharmaceutical scientist recognized globally for her outstanding contributions to the field of pharmaceutical sciences and drug discovery. A Gold Medalist and University Topper from the 2011–2017 Pharm.D batch at Annamacharya College of Pharmacy, Dr. Rekha has demonstrated exceptional academic and research excellence throughout her career. She has actively participated in over 120 National and International conferences, UGC-sponsored workshops, webinars, and academic competitions, earning 102 awards across diverse platforms including science fairs, talent search exams, essay and quiz competitions. Her prolific research output includes over 200 publications in reputed national and international journals with good impact factors, contributing significantly to the scientific community. She has been granted 25 patents and has authored 20 books/book chapters, focusing on cutting-edge areas of pharmaceutical research. Dr. Rekha has achieved an impressive citation count exceeding 434, with an h-index of 9, reflecting the influence and quality of her scholarly work (Note: Insert exact numbers as available). She has received 12 Best Speaker Awards at various global scientific congresses. A dedicated researcher and academician, she has guided numerous Pharm.D, B.Pharm, and M.Pharm research projects, and worked on over 78 major research projects. She currently serves as an Editor, Associate Editor, Peer Reviewer, and Chief Advisory Board Member for 52 reputed national and international journals. Additionally, she has held critical roles such as Chief Biological Scientist in Animal Ethics Committees and Chief Member of Human Ethics Committees. Her career is a testament to her unwavering passion for research, innovation, and academic excellence in the pharmaceutical sciences.

Profiles: Google Scholar | Staff Page

Featured Publications

Bradha, M., Balakrishnan, N., Suvitha, A., Arumanayagam, T., Rekha, M., & Others. (2022). Experimental, computational analysis of Butein and Lanceoletin for natural dye-sensitized solar cells and stabilizing efficiency by IoT. Environment, Development and Sustainability, 24(6), 8807–8822.

Kumar, B. A., Rekha, M. M., & Mubeena, T. (2016). A short review on Zika Virus past, present strategies and future prospectives. PharmaTutor, 4(7), 21–24.

Sead, F. F., Jain, V., Kumar, A., Rekha, R. M. M., Kundlas, M., Gupta, S., Kumari, M., & Others. (2025). Magnetically recoverable catalysts for efficient multicomponent synthesis of organosulfur compounds. RSC Advances, 15(5), 3928–3953.

Vivek, P., Kumar, G. S., Steephen, A., Jauhar, R. O. M. U., Suvitha, A., Rekha, M., & Others. (2021). Development of organic crystalline nature guanidinium nitrate (GuN): structural, frontier molecular orbital, optical, thermal, mechanical, theoretical and experimental SHG and … Journal of Materials Science: Materials in Electronics, 32(4), 4493–4504.

Vivek, P., Rekha, M., Steephen, A., Kowsalya, M., & Magesh, M. (2021). Meticulous review on potential nano-sized catalysts for air and water purifiers. Iranian Journal of Catalysis, 11(4).

Balaraman, A. K., Babu, M. A., Moglad, E., Mandaliya, V., Rekha, M. M., Gupta, S., & Others. (2025). Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathology – Research and Practice, 266, 155785.

Rekha, K., Aruna, R. M., Rekha, M. M., & Karthik, S. (2019). Formulation and development of bilastine tablets 20 mg. World Journal of Pharmaceutical Research, 8, 2197–224.

Wankhede, N. L., Kale, M. B., Kyada, A., Rekha, R. M. M., Chaudhary, K., Naidu, K. S., & Others. (2025). Sleep deprivation-induced shifts in gut microbiota: Implications for neurological disorders. Neuroscience, 565, 99–116.

Vivek, P., Rekha, M., Steephen, A., Jauhar, R. O. M., Kumar, G. S., Suvitha, A., & Others. (2021). Nonlinear optical crystalline nature bis(2,6-diaminopyridinium) hydrogen phthalate nitrate monohydrate (APPN): Development and its phase matching nature. Results in Optics, 3, 100075.